Susquehanna International Group, LLP Veracyte, Inc. Put Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$21.0 - $35.25 $46,200 - $77,550	-2,200 Reduced 14.86%	12,600 $428,000
Q2 2024 Aug 15, 2024	SELL	$18.86 - $23.55 $688,390 - $859,575	-36,500 Reduced 71.15%	14,800 $320,000
Q1 2024 May 07, 2024	BUY	$21.0 - $29.1 $804,300 - $1.11 Million	38,300 Added 294.62%	51,300 $1.14 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $847,960 - $1.23 Million	-43,000 Reduced 76.79%	13,000 $357,000
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $1.25 Million - $1.68 Million	56,000 New	56,000 $1.25 Million

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.02B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.